The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Emerging common themes in regulation of PIKKs and PI3Ks
Open accessAbstract
Phosphatidylinositol-3 kinase-related kinases (PIKKs) comprise a family of protein kinases that respond to various stresses, including DNA damage, blocks in DNA replication, availability of nutrients and errors in mRNA splicing. PIKKs are characterized by the presence of a conserved kinase domain (KD), whose activity is regulated by two C-terminal regions, referred to as PIKK-regulatory domain (PRD) and FRAP-ATM-TRRAP-C-terminal (FATC), respectively. Here, we review functional and structural data that implicate the PRD and FATC domains in regulation of PIKK activity, drawing parallels to phosphatidylinositol-3 kinases (PI3K), lipid kinases that have sequence similarity to PIKKs. The PI3K C-terminus, which we propose to be equivalent to the PRD and FATC domains of PIKKs, is in close proximity to the activation loop of the KD, suggesting that in PIKKs, the PRD and FATC domains may regulate kinase activity by targeting the activation loop.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145
TOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787
The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A., Powell, S. M., Riggins, G. J., et al. (2004) · Science · doi:10.1126/science.1096502 · Cited by 3,437
Patterns of somatic mutation in human cancer genomes
Greenman, C., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., Bignell, G., Davies, H., Teague, J., Butler, A., Stevens, C., et al. (2007) · Nature · doi:10.1038/nature05610 · Cited by 3,080
A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785
Sensing DNA Damage Through ATRIP Recognition of RPA-ssDNA Complexes
Zou, L., & Elledge, S. J. (2003) · Science · doi:10.1126/science.1083430 · Cited by 2,693
Somatic mutations affect key pathways in lung adenocarcinoma
Ding, L., Getz, G., Wheeler, D. A., Mardis, E. R., McLellan, M. D., Cibulskis, K., Sougnez, C., Greulich, H., Muzny, D. M., Morgan, M. B., et al. (2008) · Nature · doi:10.1038/nature07423 · Cited by 2,681
ATM and related protein kinases: safeguarding genome integrity
Shiloh, Y. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1011 · Cited by 2,577 · cited 2×
“ATM, ATR and DNA-PKcs are involved in the response to DNA damage: ATM and DNA-PKcs respond to DNA double-strand breaks (DSBs) and ATR to DNA replication blocks or other conditions that lead to formation of long stretches of single-stranded DNA (Shiloh, 2003).”
BackgroundStructure of the FKBP12-Rapamycin Complex Interacting with Binding Domain of Human FRAP
Choi, J., Chen, J., Schreiber, S. L., & Clardy, J. (1996) · Science · doi:10.1126/science.273.5272.239 · Cited by 929
Mutant PIK3CA promotes cell growth and invasion of human cancer cells.
Samuels, Y., Diaz, L. A., Schmidt-Kittler, O., Cummins, J. M., DeLong, L., Cheong, I., Rago, C., Huso, D. L., Lengauer, C., Kinzler, K. W., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.05.014 · Cited by 915
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic
Kang, S., Bader, A. G., & Vogt, P. K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408864102 · Cited by 823
O'Driscoll, M., Ruiz-Perez, V. L., Woods, C. G., Jeggo, P. A., & Goodship, J. A. (2003) · Nature Genetics · doi:10.1038/ng1129 · Cited by 794
TopBP1 Activates the ATR-ATRIP Complex
Kumagai, A., Lee, J., Yoo, H. Y., & Dunphy, W. G. (2006) · Cell · doi:10.1016/j.cell.2005.12.041 · Cited by 746
A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM
Sun, Y., Jiang, X., Chen, S., Fernandes, N., & Price, B. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504211102 · Cited by 738 · cited 7×
“In the case of ATM, binding of the MRN complex to its N-terminus (You et al, 2005) may affect the conformation of its FATC domain, somewhat analogous to how Ras affects the conformation of the C-terminal lobe of the PI3K KD, whereas Tip60 targets the PRD for acetylation (Sun et al, 2005, 2007).”
BackgroundInfluentialSekulić, A., Hudson, C. C., Homme, J. L., Yin, P., Otterness, D. M., Karnitz, L. M., & Abraham, R. T. (2000) · PubMed · Cited by 710
The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins
McMahon, S. B., Van Buskirk, H. A., Dugan, K. A., Copeland, T. D., & Cole, M. D. (1998) · Cell · doi:10.1016/s0092-8674(00)81479-8 · Cited by 693
Crystal Structure and Functional Analysis of Ras Binding to Its Effector Phosphoinositide 3-Kinase γ
Pacold, M. E., Suire, S., Perisic, O., Lara-Gonzalez, S., Davis, C. T., Walker, E. H., Hawkins, P. T., Stephens, L., Eccleston, J. F., & Williams, R. L. (2000) · Cell · doi:10.1016/s0092-8674(00)00196-3 · Cited by 602
Class I PI3K in oncogenic cellular transformation
Zhao, L., & Vogt, P. K. (2008) · Oncogene · doi:10.1038/onc.2008.244 · Cited by 594
Phosphorylation of Mammalian Target of Rapamycin (mTOR) at Ser-2448 IsMediated by p70S6 Kinase
Chiang, G. G., & Abraham, R. T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501707200 · Cited by 562
The Structure of a Human p110α/p85α Complex Elucidates the Effects of Oncogenic PI3Kα Mutations
Huang, C.-H., Mandelker, D., Schmidt-Kittler, O., Samuels, Y., Velculescu, V. E., Kinzler, K. W., Vogelstein, B., Gabelli, S. B., & Amzel, L. M. (2007) · Science · doi:10.1126/science.1150799 · Cited by 560
The Gβγ Sensitivity of a PI3K Is Dependent upon a Tightly Associated Adaptor, p101
Stephens, L. R., Eguinoa, A., Erdjument-Bromage, H., Lui, M., Cooke, F., Coadwell, J., Smrcka, A. S., Thelen, M., Cadwallader, K., Tempst, P., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80187-7 · Cited by 557
Chen, J., Zheng, X. F., Brown, E. J., & Schreiber, S. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4947 · Cited by 556 · cited 3×
“First, the FRB domain of mTOR is bound by the complex of rapamycin with FKBP12 and rapamycin is a potent inhibitor of mTOR kinase activity (Stan et al, 1994; Chen et al, 1995; Choi et al, 1996).”
BackgroundInfluentialYu, J., Zhang, Y., McIlroy, J., Rordorf-Nikolic, T., Orr, G. A., & Backer, J. M. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.3.1379 · Cited by 520
PIK-Related Kinases: DNA Repair, Recombination, and Cell Cycle Checkpoints
Keith, C. T., & Schreiber, S. L. (1995) · Science · doi:10.1126/science.270.5233.50 · Cited by 518
Breast Cancer–Associated PIK3CA Mutations Are Oncogenic in Mammary Epithelial Cells
Isakoff, S. J., Engelman, J. A., Irie, H. Y., Luo, J., Brachmann, S. M., Pearline, R. V., Cantley, L. C., & Brugge, J. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2612 · Cited by 509
The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc
McMahon, S. B., Wood, M. A., & Cole, M. D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.2.556-562.2000 · Cited by 494 · cited 1×
“Finally, TRRAP functions as part of a multiprotein co-activator complex possessing histone acetyltranferase activity that is important for the transcriptional activity of c-Myc and other transcription factors (McMahon et al, 2000).”
BackgroundStructural insights into phosphoinositide 3-kinase catalysis and signalling
Walker, E. H., Perisic, O., Ried, C., Stephens, L., & Williams, R. L. (1999) · Nature · doi:10.1038/46319 · Cited by 494
ATM Activation and Its Recruitment to Damaged DNA Require Binding to the C Terminus of Nbs1
You, Z., Chahwan, C., Bailis, J., Hunter, T., & Russell, P. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5363-5379.2005 · Cited by 432
Cancer-specific mutations in PIK3CA are oncogenic in vivo
Bader, A. G., Kang, S., & Vogt, P. K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510857103 · Cited by 420
Mechanism of Two Classes of Cancer Mutations in the Phosphoinositide 3-Kinase Catalytic Subunit
Miled, N., Yan, Y., Hon, W.-C., Perisic, O., Zvelebil, M., Inbar, Y., Schneidman-Duhovny, D., Wolfson, H. J., Backer, J. M., & Williams, R. L. (2007) · Science · doi:10.1126/science.1135394 · Cited by 410
Carpenter, C. L., Auger, K. R., Chanudhuri, M., Yoakim, M., Schaffhausen, B., Shoelson, S., & Cantley, L. C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98375-4 · Cited by 388
Rare cancer-specific mutations in PIK3CA show gain of function
Gymnopoulos, M., Elsliger, M.-A., & Vogt, P. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701005104 · Cited by 376
TopBP1 activates ATR through ATRIP and a PIKK regulatory domain
Mordes, D. A., Glick, G. G., Zhao, R., & Cortez, D. (2008) · Genes & Development · doi:10.1101/gad.1666208 · Cited by 373
Role of GTP Hydrolysis in Fission of Caveolae Directly from Plasma Membranes
Schnitzer, J. E., Oh, P., & McIntosh, D. P. (1996) · Science · doi:10.1126/science.274.5285.239 · Cited by 371
Functional Analysis of PIK3CA Gene Mutations in Human Colorectal Cancer
Ikenoue, T., Kanai, F., Hikiba, Y., Obata, T., Tanaka, Y., Imamura, J., Ohta, M., Jazag, A., Guleng, B., Tateishi, K., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4114 · Cited by 369
Identification of S6 Kinase 1 as a Novel Mammalian Target of Rapamycin (mTOR)-phosphorylating Kinase
Holz, M. K., & Blenis, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504045200 · Cited by 361
Peterson, R. T., Beal, P. A., Comb, M. J., & Schreiber, S. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.7416 · Cited by 339
Zhao, J. J., Liu, Z., Wang, L., Shin, E., Loda, M. F., & Roberts, T. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508988102 · Cited by 324
DNA Damage-Induced Acetylation of Lysine 3016 of ATM Activates ATM Kinase Activity
Sun, Y., Xu, Y., Roy, K., & Price, B. D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01382-07 · Cited by 319
FAT: a novel domain in PIK-related kinases
Bosotti, R., Isacchi, A., & Sonnhammer, E. L. L. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01563-2 · Cited by 313
van der Burg, M., IJspeert, H., Verkaik, N. S., Turul, T., Wiegant, W. W., Morotomi-Yano, K., Mari, P.-O., Tezcan, I., Chen, D. J., Zdzienicka, M. Z., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci37141 · Cited by 289
Spagnolo, L., Rivera-Calzada, A., Pearl, L. H., & Llorca, O. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.04.013 · Cited by 270
The ATRs, ATMs, and TORs Are Giant HEAT Repeat Proteins
Perry, J., & Kleckner, N. (2003) · Cell · doi:10.1016/s0092-8674(03)00033-3 · Cited by 268
Ball, H. L., Myers, J. S., & Cortez, D. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-11-1006 · Cited by 242
Using structure to define the function of phosphoinositide 3‐kinase family members
Domin, J., & Waterfield, M. D. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00617-0 · Cited by 233
Regulation of the p85/p110α Phosphatidylinositol 3′-Kinase
Yu, J., Wjasow, C., & Backer, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30199 · Cited by 181
Jiang, X., Sun, Y., Chen, S., Roy, K., & Price, B. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513172200 · Cited by 168
Brunn, G. J., Fadden, P., Haystead, T. A. J., & Lawrence, J. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.51.32547 · Cited by 168
Cancer-specific mutations in phosphatidylinositol 3-kinase
Vogt, P. K., Kang, S., Elsliger, M., & Gymnopoulos, M. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.05.005 · Cited by 157
Interaction between FKBP12-rapamycin and TOR involves a conserved serine residue.
Stan, R., McLaughlin, M. M., Cafferkey, R., Johnson, R. K., Rosenberg, M. J., & Livi, G. P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31592-8 · Cited by 143
Dames, S. A., Mulet, J. M., Rathgeb–Szabo, K., Hall, M. N., & Grzesiek, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501116200 · Cited by 134
Rivera-Calzada, Á., Maman, J. D., Spagnolo, L., Pearl, L. H., & Llorca, Ó. (2005) · Structure · doi:10.1016/j.str.2004.12.006 · Cited by 127
Structure of TOR and Its Complex with KOG1
Adami, A., García‐Álvarez, B., Arias‐Palomo, E., Barford, D., & Llorca, Ó. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.040 · Cited by 111
Takahashi, T., Hara, K., Inoue, H., Kawa, Y., Tokunaga, C., Sujuti, H., Yoshino, K., Kuroda, Y., & Yonezawa, K. (2000) · Genes to Cells · doi:10.1046/j.1365-2443.2000.00365.x · Cited by 110
Fang, N. Y., Greiner, T. C., Weisenburger, D. D., Chan, W. C., Vose, J. M., Smith, L. M., Armitage, J. O., Mayer, R. A., Pike, B. L., Collins, F. S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0831102100 · Cited by 107
Mutations at the ataxia‐telangiectasia locus and clinical phenotypes of A–T patients
Li, A., & Swift, M. (2000) · American Journal of Medical Genetics · Cited by 103
The role of SMG-1 in nonsense-mediated mRNA decay
Yamashita, A., Kashima, I., & Ohno, S. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.10.002 · Cited by 95
Role of the C Terminus of Mec1 Checkpoint Kinase in Its Localization to Sites of DNA Damage
Nakada, D., Hirano, Y., Tanaka, Y., & Sugimoto, K. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-05-0405 · Cited by 60
Llorca, Ó., Rivera-Calzada, Á., Grantham, J., & Willison, K. R. (2003) · Oncogene · doi:10.1038/sj.onc.1206649 · Cited by 55
Morita, T., Yamashita, A., Kashima, I., Ogata, K., Ishiura, S., & Ohno, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610159200 · Cited by 54
Cavalieri, S., Funaro, A., Porcedda, P., Turinetto, V., Migone, N., Gatti, R. A., & Brusco, A. (2006) · Human Mutation · doi:10.1002/humu.9454 · Cited by 39
Becker, K., Hohoff, C., Schmitt, B., Christen, H. ‐., Neubauer, B. A., Sandrieser, T., & Becker, C. (2006) · Human Mutation · doi:10.1002/humu.9455 · Cited by 30
Cited by
PI3K and cancer: lessons, challenges and opportunities
Fruman, D. A., & Rommel, C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4204 · Cited by 1,709
The ATM protein kinase: regulating the cellular response to genotoxic stress, and more
Shiloh, Y., & Ziv, Y. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3546 · Cited by 1,649
DNA Damage Sensing by the ATM and ATR Kinases
Marechal, A., & Zou, L. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012716 · Cited by 1,514
Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer
Yu, L., Wei, J., & Liu, P. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.06.019 · Cited by 763
ATM and ATR as therapeutic targets in cancer
Weber, A. M., & Ryan, A. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.001 · Cited by 635
Metadata
- Authors
- Lempiäinen, H., & Halazonetis, T. D.
- Venue
- The EMBO Journal
- Published
- 2009-09-24
- Volume
- 28
- Issue
- 20
- Pages
- 3067-3073
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- OpenAlex
- W2088857928
- Cited by
- 298
- References
- 63
- FWCI
- 7.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.